Clinical Trial Update: Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET) [Phase 2]

View source ↗

Summary

Phase 2 trial update for ENT-01 (oral) in Parkinson's disease-related constipation completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Parkinson Disease

Drugs mentioned

• ENT-01

Snippet

Sponsor: Enterin Inc. | Conditions: Constipation, Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-12-04